Clinical Trial Update: Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating intraperitoneal carboplatin with intravenous paclitaxel and bevacizumab in untreated ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: David O'Malley | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 1 | Status: COMPLETED